The network's new comedy series features an exaggerated depiction of the neurological condition for laughs. Experts say that ...
DelveInsight's Narcolepsy Market Insights report includes a comprehensive understanding of current treatment practices, narcolepsy emerging drugs, market share of individual therapies, and current and ...
DelveInsight reports that the narcolepsy market reached about $2.5 billion across major regions in 2024, with the USA ...
Paediatric patients with narcolepsy will now have access to Avadel’s Lumryz (sodium oxybate) after the US Food and Drug Administration (FDA) approved a supplemental new drug application. The expanded ...
16don MSN
TD Cowen Asserts Buy Rating as Alkermes plc (ALKS) Delivers Topline Results for Narcolepsy Treatment
Alkermes Plc (NASDAQ:ALKS) is one of the best breakout stocks to invest in. On November 12, Alkermes Plc (NASDAQ:ALKS) delivered positive topline clinical trial data for its narcolepsy treatment, ...
The World Health Organization urged more investigation into possible links between GlaxoSmithKline's Pandemrix and other H1N1 flu vaccines and narcolepsy, a rare sleeping disorder. The WHO advisory ...
These review results were mixed on the use of immunotherapy to treat narcolepsy, with benefits typically being temporary. The chronic sleep disorder narcolepsy is characterized by excessive daytime ...
Narcolepsy was linked to high blood pressure, hyperlipidemia, and diabetes on top of outright cardiovascular disease events in a retrospective cohort study. Notably, patients with narcolepsy started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback